Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SCT B41

Next Previous
Drug Profile

SCT B41

Alternative Names: SCT-B41

Latest Information Update: 03 Jul 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sinocelltech
  • Class Antineoplastics; Immunotherapies; Trispecific antibodies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II/III Non-small cell lung cancer

Most Recent Events

  • 26 Jun 2026 Sinocelltech plans a phase-I/II trial for Solid tumours (Late-stage disease, Combination therapy) (IV) in June 2026 (NCT07665970),
  • 27 May 2026 Sinocelltech plans a phase II trial for Non-Small Cell Lung Cancer (Late-stage disease, Metastatic disease, Combination therapy, Second-line therapy or greater) in China in May 2026 (IV, infusion) (NCT07609251)
  • 21 May 2026 Sinocelltech plans a phase I/II trial in Solid tumours (Late-stage disease, Combination therapy) (IV) (NCT07594028)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top